June 9 (Reuters) - Canada's main stock index edged lower on Tuesday as resource and technology shares lost ground, while investors awaited the initial public offering of generic drug manufacturer Apotex.
The Toronto Stock Exchange's S&P/TSX composite index ended down 67.05 points, or 0.2%, at 34,411.69, extending its pullback from a record closing high last Thursday.
o The S&P 500 and the Nasdaq indexes also fell as a rebound in technology shares faded.
o "This is not a cheap market on balance," said Barry Schwartz, chief investment officer at Baskin Wealth Management. "The glamour names, the favorite names right now - some of them are quite expensive and due for a reasonable pullback or a mini correction."
o Shares of electronic equipment company Celestica fell 4.1%, which helped drag the technology sector 1.2% lower.
o Energy was down 3.1%, as the price of oil settled 3.4% lower at $88.20 a barrel after Iran and Israel said they had halted attacks on each other.
o The materials group, which includes metal mining shares, lost 1.7%, with shares of Valor Gold tumbling 21.6%.
o The price of gold fell 1.6% ahead of a key U.S. inflation report.
o Most of the other 10 major sectors ended higher, including financials, which added 1%.
o Consumer staples was another standout, rising 1.7%.
o Apotex said that its initial public offering had been upsized to approximately C$1.3 billion.
o "We haven't seen a lot of high-profile IPOs on the TSX, and it would be nice to get more diversified companies and businesses and industries on the TSX which are significant in size," Schwartz said.
o Investors expect the Bank of Canada to leave its benchmark interest rate on hold at 2.25% for a fifth straight policy decision on Wednesday.
(Reporting by Fergal Smith in Toronto and Tharuniyaa Lakshmi in Bengaluru; Editing by Shailesh Kuber and Will Dunham)
By Fergal Smith
